First Dose of the BNT162b2 mRNA COVID-19 Vaccine Reduces Symptom Duration and Viral Clearance in Healthcare Workers

MLA

Luca Coppeta, et al. “First Dose of the BNT162b2 MRNA COVID-19 Vaccine Reduces Symptom Duration and Viral Clearance in Healthcare Workers.” Vaccines, vol. 9, no. 6, June 2021, p. 659. EBSCOhost, https://doi.org/10.3390/vaccines9060659.

APA

Luca Coppeta, Ottavia Balbi, Zaira Grattagliano, Grazia Genga Mina, Antonio Pietroiusti, Andrea Magrini, Matteo Bolcato, & Marco Trabucco Aurilio. (2021). First Dose of the BNT162b2 mRNA COVID-19 Vaccine Reduces Symptom Duration and Viral Clearance in Healthcare Workers. Vaccines, 9(6), 659. https://doi.org/10.3390/vaccines9060659

Chicago

Luca Coppeta, Ottavia Balbi, Zaira Grattagliano, Grazia Genga Mina, Antonio Pietroiusti, Andrea Magrini, Matteo Bolcato, and Marco Trabucco Aurilio. 2021. “First Dose of the BNT162b2 MRNA COVID-19 Vaccine Reduces Symptom Duration and Viral Clearance in Healthcare Workers.” Vaccines 9 (6): 659. doi:10.3390/vaccines9060659.